CytoMed Therapeutics Ltd Quarterly Liabilities in SGD from Q4 2021 to Q4 2023

Taxonomy & unit: ifrs-full: SGD and USD
Summary: CytoMed Therapeutics Ltd quarterly Liabilities history and growth rate from Q4 2021 to Q4 2023.
CytoMed Therapeutics Ltd Liabilities for the quarter ending December 31, 2023 was SGD1.12M, a 75.8% decline year-over-year.

Liabilities, Quarterly (SGD)

Liabilities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	1.12M	-3.52M	-75.8%	Dec 31, 2023	20-F	2024-04-22
Q4 2022	4.64M	+1.15M	+32.9%	Dec 31, 2022	20-F	2024-04-22
Q4 2021	3.49M			Dec 31, 2021	20-F	2023-05-01

* An asterisk sign (*) next to the value indicates that the value is likely invalid.